Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis.
- DOI
- 10.1136/ard-2023-223862
- Published
- 2023 Sep
- Container
- Annals of the rheumatic diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/ard-2023-223862,
title = {Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis.},
author = {Denton CP and Xu S and Zhang F and Maclean RH and Clark KEN and Borchert S and Hussain RI and Klingelhöfer J and Hallén J and Ong VH},
year = {2023},
journal = {Annals of the rheumatic diseases},
doi = {10.1136/ard-2023-223862},
url = {https://doi.org/10.1136/ard-2023-223862}
}RIS
TY - JOUR TI - Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis. AU - Denton CP AU - Xu S AU - Zhang F AU - Maclean RH AU - Clark KEN AU - Borchert S AU - Hussain RI AU - Klingelhöfer J AU - Hallén J AU - Ong VH PY - 2023 JO - Annals of the rheumatic diseases DO - 10.1136/ard-2023-223862 UR - https://doi.org/10.1136/ard-2023-223862 ER -
APA
CP, D., S, X., F, Z., RH, M., KEN, C., S, B., RI, H., J, K., J, H., & VH, O. (2023). Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis.. Annals of the rheumatic diseases. https://doi.org/10.1136/ard-2023-223862
Source records
- pubmed · retrieved 2026-09-27T08:39:20.439Z